Cerity Partners’s Innospec IOSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.55M Buy
31,315
+8,802
+39% +$697K ﹤0.01% 1459
2026
Q1
$1.64M Buy
22,513
+3,204
+17% +$249K ﹤0.01% 1591
2025
Q4
$1.48M Sell
19,309
-1,733
-8% -$131K ﹤0.01% 1511
2025
Q3
$1.62M Buy
21,042
+6,209
+42% +$518K ﹤0.01% 1384
2025
Q2
$1.25M Buy
14,833
+1,615
+12% +$141K ﹤0.01% 1424
2025
Q1
$1.25M Sell
13,218
-29
-0.2% -$3.07K ﹤0.01% 1325
2024
Q4
$1.5M Sell
13,247
-417
-3% -$47.7K ﹤0.01% 1236
2024
Q3
$1.55M Buy
13,664
+10,445
+324% +$1.22M ﹤0.01% 1207
2024
Q2
$398K Sell
3,219
-14,515
-82% -$1.82M ﹤0.01% 1658
2024
Q1
$2.29M Buy
+17,734
New +$2.15M 0.01% 913
2017
Q2
Sell
-4,739
Closed -$307K 390
2017
Q1
$307K Buy
+4,739
New +$317K 0.03% 332

Other funds holding IOSP

Cerity Partners's IOSP Position: Q2 2026 in Review

Cerity Partners increased its Innospec (IOSP) stake by 39% in Q2 2026, buying an estimated $697K and bringing the position to 31,315 shares worth $2.55M. The position accounts for ﹤0.01% of the portfolio, ranked #1459.

Cerity Partners first reported a position in IOSP in Q1 2017 and has held it in 11 quarters since. 282 funds tracked by Wall St. Rank hold IOSP as of Q2 2026.

  • Cerity Partners held 31,315 shares of Innospec worth $2.55M as of Q2 2026.
  • Cerity Partners bought 8,802 Innospec shares in Q2 2026, an estimated $697K.
  • Innospec made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #1459 holding.
  • Cerity Partners first reported a position in Innospec in Q1 2017 and has held it in 11 quarters since.
  • 282 funds tracked by Wall St. Rank held Innospec as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.